Choosing an aqp4 antibody, a parkin antibody or a ryr2 antibody: why membrane and very large targets defeat a default western blot protocol, what conformational epitopes mean for a detection assay, and the sample preparation each of these demands

What each target demands

1. Do not boil a multipass membrane protein. Heating a multipass membrane channel in sample buffer aggregates it, and the aggregate sits in the well rather than running. Incubating at a lower temperature, commonly thirty seven or seventy degrees, is what makes the band appear, and this single change rescues a great many apparently dead antibodies.
2. Use a low percentage gel for very large targets. A protein of several hundred kilodaltons will not resolve on a standard gel and may barely leave the stacking layer. A low percentage or gradient gel, a longer run and a wet transfer with extended time are what get it onto a membrane.
3. Check whether the epitope is conformational. Antibodies raised against folded extracellular loops often fail on a denatured blot and work well on intact cells. Read which immunogen was used and which applications carry actual data, because the application list is frequently aspirational.
4. Expect modification to change the picture. Ubiquitination and other modifications produce ladders and shifted bands that look like non-specific binding. For targets in that biology, a smear or a ladder may be the real signal and a single clean band may be the artefact.
5. Use a genetic negative wherever one exists. A knockout or knockdown sample is the control that settles specificity for all three. Where none exists, an overexpression positive and a second antibody against a different epitope together are the next best evidence.

Extraction before electrophoresis

Membrane proteins need a detergent that solubilises without denaturing the epitope, and the choice interacts with the antibody. A lysate that looks fine by total protein can be missing the target entirely if the detergent did not extract it.

For very large targets, shearing during lysis fragments them. Gentle lysis and avoiding repeated pipetting matter more here than in ordinary work.

Immunostaining these targets

Retrieval conditions differ substantially between a membrane channel and a cytoplasmic ligase, so test citrate and a higher pH buffer side by side on a known positive rather than inheriting a protocol.

For a channel with a strongly polarised distribution, the staining pattern itself is part of the validation: a reagent that stains the right cells in the wrong subcellular pattern is suspect regardless of intensity.

Buying and recording

Read which application each piece of datasheet evidence supports, and buy against the application you will run. For all three of these targets, a reagent good in one application and poor in another is common and expected.

Record the catalogue number, lot, dilution and the exact denaturation and transfer conditions in the method. For targets this protocol-sensitive, a method without those numbers cannot be repeated by anyone including you.

Common questions

Why does my membrane protein not appear on a western blot?

Most often because the sample was boiled and the protein aggregated in the well. Try thirty seven or seventy degrees instead of ninety five, and check whether the antibody's epitope is conformational and therefore lost on a denatured blot.

How do I blot a very large protein?

A low percentage or gradient gel, a long run, and a wet transfer with extended time and often reduced methanol. Standard conditions leave proteins of several hundred kilodaltons in the gel, which reads as an absent target.

What does a conformational epitope mean in practice?

The antibody recognises the folded shape, so it works on intact cells and fails on a denatured blot. Applications are not interchangeable for such a reagent and the datasheet should show data per application.

Why is my blot a ladder rather than a band?

For targets in ubiquitin biology, a ladder is often the real signal rather than non-specific binding. Interpreting it needs the genetic control and a treatment that changes the modification, not a cleaner antibody.

Browse by service class

• Compare Gene synthesis on advertised prices